Table 2 Clinical treatment, test results, and adherence to IDSA guidelines for 103 adults with uncomplicated UTI

 Attending or PA

65.0

(55–74.2)

47.2

(30.4–64.5)

74.6

(62.5–84.5)

0.01

 Resident

35.0

(25.8–45)

52.8

(35.5–69.6)

25.4

(15.5–37.5)

 Ciprofloxacin

59.2

(49.1–68.8)

47.2

(30.4–64.5)

65.7

(53.1–76.8)

0.09

 Nitrofurantoin

20.4

(13.1–29.5)

22.2

(10.1–39.2)

19.4

(10.8–30.9)

 TMP-SMX

18.4

(11.5–27.3)

25.0

(12.1–42.2)

14.9

(7.4–25.7)

 Other

1.9

(0.2–6.8)

5.6

0.7–18.7)

0.0

(0.0–5.4)

 Positive

76.7

(67.3–84.5)

72.2

(54.8–85.8)

79.1

(67.4–88.1)

0.43

 Negative

23.3

(15.5–32.7)

27.8

(14.2–45.2)

20.9

(11.9–32.6)

 Escherichia coli

60.6

(42.1–77.1)

50.0

(24.7–75.3)

70.6

(44–89.7)

0.23

 Other pathogen

39.4

(22.9–57.9)

50.0

(24.7–75.3)

29.4

(10.3–56)

Non-adherence to guidelines

63.1

(53.0–72.4)

63.9

(46.2–79.2)

62.7

(50–74.2)

0.90